$TIKK
TEL INSTRUMENT ELECTRONICS CORP Stock $tikk

$tikk Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000118518524000796 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$1.777M	$2.842M
YoY Change	13.56%	-0.86%
Cost Of Revenue	$1.570M	$2.096M
YoY Change	30.26%	33.32%
Gross Profit	$206.9K	$745.9K
YoY Change	-42.43%	-42.38%
Gross Profit Margin	11.64%	26.24%
Selling, General & Admin	$550.5K	$542.3K
YoY Change	5.64%	-7.27%
% of Gross Profit	266.0%	72.71%
Research & Development	$656.1K	$131.6K
YoY Change	106.5%	-54.52%
% of Gross Profit	317.04%	17.65%
Depreciation & Amortization	$9.030K	$9.030K
YoY Change	-25.12%	-26.43%
% of Gross Profit	4.36%	1.21%
Operating Expenses	$1.207M	$674.0K
YoY Change	43.85%	-22.91%
Operating Profit	-$999.6K	$71.92K
YoY Change	108.56%	-82.89%
Interest Expense		-$18.45K
YoY Change		-58.46%
% of Operating Profit		-25.65%
Other Income/Expense, Net	-$31.52K	-$18.45K
YoY Change	-75.59%	-58.47%
Pretax Income	-$1.031M	$53.48K
YoY Change	69.48%	-85.77%
Income Tax	-$216.5K	$11.23K
% Of Pretax Income		21.0%
Net Earnings	-$814.6K	$42.25K
YoY Change	87.2%	-85.69%
Net Earnings / Revenue	-45.83%	1.49%
Basic Earnings Per Share	-$0.28	-$0.02
Diluted Earnings Per Share	-$0.28	-$0.02
COMMON SHARES
Basic Shares Outstanding	3.256M shares	3.256M shares
Diluted Shares Outstanding	3.256M shares	3.256M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$149.6K
YoY Change		-96.7%
Cash & Equivalents	$242.4K	$149.6K
Short-Term Investments
Other Short-Term Assets		$212.8K
YoY Change		-90.51%
Inventory	$4.990M	$5.208M
Prepaid Expenses	$172.9K	$185.1K
Receivables	$813.8K	$1.764M
Other Receivables	$5.000K	$211.00
Total Short-Term Assets	$6.252M	$7.334M
YoY Change	10.94%	-36.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$55.33K	$64.17K
YoY Change	-40.63%	-26.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$35.11K	$35.11K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$3.967M	$3.811M
YoY Change	-7.22%	-8.07%
TOTAL ASSETS
Total Short-Term Assets	$6.252M	$7.334M
Total Long-Term Assets	$3.967M	$3.811M
Total Assets	$10.22M	$11.15M
YoY Change	3.11%	-29.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.009M	$1.243M
YoY Change	66.14%	296.81%
Accrued Expenses		$649.8K
YoY Change		-90.86%
Deferred Revenue
YoY Change
Short-Term Debt		$1.081M
YoY Change		56.59%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.987M	$3.031M
YoY Change	40.23%	-63.11%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities	$41.55K	$43.52K
YoY Change	-16.0%	-15.39%
Total Long-Term Liabilities	$41.55K	$43.52K
YoY Change	-16.0%	-15.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.987M	$3.031M
Total Long-Term Liabilities	$41.55K	$43.52K
Total Liabilities	$4.133M	$4.248M
YoY Change	16.67%	-56.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.779M	-$5.965M
YoY Change	4.48%	-1.47%
Common Stock	$325.6K	$325.6K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.085M	$6.898M
YoY Change
Total Liabilities & Shareholders Equity	$10.22M	$11.15M
YoY Change	3.11%	-29.36%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$814.6K	$42.25K
YoY Change	87.2%	-85.69%
Depreciation, Depletion And Amortization	$9.030K	$9.030K
YoY Change	-25.12%	-26.43%
Cash From Operating Activities		-$373.0K
YoY Change		-152.81%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$390.5K
YoY Change
NET CHANGE
Cash From Operating Activities		-$373.0K
Cash From Investing Activities		$0.00
Cash From Financing Activities		$390.5K
Net Change In Cash		$17.54K
YoY Change		-97.47%
FREE CASH FLOW
Cash From Operating Activities		-$373.0K
Capital Expenditures		$0.00
Free Cash Flow		-$373.0K
YoY Change		-153.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	dei	Document Type DocumentType	10-Q
CY2024Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	East Rutherford
CY2024Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07073
CY2024Q2	dei	City Area Code CityAreaCode	201
CY2024Q2	dei	Local Phone Number LocalPhoneNumber	933-1600
CY2024Q2	dei	Security12b Title Security12bTitle	N/A
CY2024Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q2	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3255887	shares
CY2024Q2	us-gaap	Cash Cash	149550	usd
CY2024Q1	us-gaap	Cash Cash	132013	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1763680	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1110548	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	5208229	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	5411644	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	213024	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	214161	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	7334483	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	6868366	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	64165	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	73195	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1272700	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1324463	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2439427	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2450657	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35109	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35109	usd
CY2024Q2	us-gaap	Assets Assets	11145884	usd
CY2024Q1	us-gaap	Assets Assets	10751790	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1242906	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1276935	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	265948	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	248713	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	57778	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	72803	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	204064	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	210111	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	179748	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	120027	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1000000	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	690000	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	80500	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3030944	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2618589	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1068636	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1114352	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	43524	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	45501	usd
CY2024Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	104963	usd
CY2024Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	119721	usd
CY2024Q2	us-gaap	Liabilities Liabilities	4248067	usd
CY2024Q1	us-gaap	Liabilities Liabilities	3898163	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	7000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	7000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3255887	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3255887	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3255887	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3255887	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	325586	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	325586	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6286607	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6379085	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5964710	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6006958	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	6897817	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6853627	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11145884	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10751790	usd
CY2024Q2	us-gaap	Revenues Revenues	2842176	usd
CY2023Q2	us-gaap	Revenues Revenues	2866929	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2096274	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1572380	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	745902	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1294549	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	542340	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	584858	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	131638	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	289441	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	673978	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	874299	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	71924	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	420250	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	11	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	39289	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	18457	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	13455	usd
CY2024Q2	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	70245	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18446	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-44411	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	53478	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	375839	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11230	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	80547	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	42248	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	295292	usd
CY2024Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	94420	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	80000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-52172	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	215292	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3255887	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3255887	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3255887	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5215665	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6853627	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1942	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	42248	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	6897817	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5781637	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3269	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	295292	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6080198	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	42248	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	295292	usd
CY2024Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	11230	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	80547	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9030	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12274	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	51763	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	49786	usd
CY2024Q2	us-gaap	Provision For Other Losses ProvisionForOtherLosses	4127	usd
CY2023Q2	us-gaap	Provision For Other Losses ProvisionForOtherLosses	1004	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1942	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3269	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	653132	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	336663	usd
CY2024Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-199288	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21600	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1137	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-573177	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-34029	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-9360	usd
CY2024Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	17235	usd
CY2023Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	64416	usd
CY2024Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-29783	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-32501	usd
CY2024Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-51763	usd
CY2023Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-49786	usd
CY2024Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1977	usd
CY2023Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1978	usd
CY2024Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	59721	usd
CY2023Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	8150	usd
CY2024Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	0	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	70245	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-372963	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	706272	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13983	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13983	usd
CY2024Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	310000	usd
CY2023Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2024Q2	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	80500	usd
CY2023Q2	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	390500	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	17537	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	692289	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	132013	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5850481	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	149550	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6542770	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	149550	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4531637	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2011133	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	149550	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6542770	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132013	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3839398	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2011083	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	132013	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5850481	usd
CY2024Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2024Q2	us-gaap	Interest Paid Net InterestPaidNet	17869	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	13455	usd
CY2024Q2	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration:underline">Note 1</span> – <span style="text-decoration:underline">Business, Organization and Liquidity</span></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Business and Organization</i></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Tel-Instrument Electronics Corp. (“Tel,” “TIC” or the “Company”) has been in business since 1947. The Company is a leading designer and manufacturer of avionics test and measurement instruments for the global, commercial air transport, general aviation, and government/military defense markets. Tel provides instruments to test, measure, calibrate, and repair a wide range of airborne navigation and communication equipment. The Company sells its equipment in both domestic and international markets. Tel continues to develop new products in anticipation of customers’ needs and to maintain its strong market position. Its development of multi-function testers has made it easier for customers to perform ramp tests with less operator training, fewer test sets, and lower product support costs. The Company has become a major manufacturer and supplier of Identification Friend or Foe (“IFF”) flight line test equipment over the last two decades.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is publicly traded and was quoted on the Over-the-Counter Market Place (“OTCQB”) under the symbol “TIKK.”</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Liquidity </i></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On June 30, 2024, the Company had positive working capital of $4,303,539 as compared to working capital of $4,249,777 on March 31, 2024. This included $149,550 of cash on hand and $1.8 million of accounts receivable.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company had a $7 million sales backlog on June 30, 2024.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On April 1, 2023, Bank of America further extended the maturity date of our line of credit from June 30, 2024 to July 31, 2024. Bank of America has extended the line of credit while in process of formally renewing the line of credit for an additional period. Additionally, the line of credit available was increased from $690,000 to $1,000,000. The line of credit was fully drawn upon for $1,000,000 on June 30, 2024. The Company repaid $75,000 of this line of credit in July 2024.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">During June 2024, the Company’s CEO provided short term advances totaling $105,500. During July 2024, an additional $40,000 was provided in short term advances of which $25,000 was repaid during July 2024, with a balance owed as of August 13, 2024 of $120,500.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company believes it has sufficient cash on hand and expected cash flow from operations for the next twelve months due to the increase in business and the opportunities we have included in our projections. Revenues and profits are expected to improve in fiscal year 2025 due to the success of our SDR-OMNI product and the commencement of CRAFT ECP production.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on the foregoing, we believe that our expected cash flows from operations, and fulfillment of our $7 million open orders will be sufficient to operate in the normal course of business for next 12 months from the issuance date of these unaudited condensed consolidated financial statements.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Currently, the Company has no material future capital expenditure requirements.</p>
CY2024Q2	tikk	Working Capital WorkingCapital	4303539	usd
CY2024Q1	tikk	Working Capital WorkingCapital	4249777	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	149550	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	1800000	usd
CY2024Q2	tikk	Backlog Backlog	7000000	usd
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	1000000	usd
CY2024Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	75000	usd
CY2024Q2	us-gaap	Extended Product Warranty Description ExtendedProductWarrantyDescription	The extended warranties sold by the Company provide a level of assurance beyond the coverage for defects that existed at the time of a sale or against certain types of covered damage with coverage terms ranging from 2 to 7 years.
CY2024Q2	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	162741	usd
CY2024Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	179422	usd
CY2024Q2	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	16681	usd
CY2023Q2	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	34006	usd
CY2024Q1	us-gaap	Deferred Revenue And Credits DeferredRevenueAndCredits	179422	usd
CY2024Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	16681	usd
CY2024Q2	us-gaap	Deferred Revenue And Credits DeferredRevenueAndCredits	162741	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3246587	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3237557	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	64165	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	73195	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9030	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45823	usd
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	1000000	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	690000	usd
CY2024Q2	us-gaap	Revenues Revenues	2842176	usd
CY2023Q2	us-gaap	Revenues Revenues	2866929	usd
CY2024Q2	us-gaap	Payments For Commissions PaymentsForCommissions	10026	usd
CY2023Q2	us-gaap	Payments For Commissions PaymentsForCommissions	1600	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8570	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8570	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1763680	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1110548	usd
CY2024Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	2896263	usd
CY2024Q1	us-gaap	Other Inventory Supplies OtherInventorySupplies	2835120	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	2624754	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2912737	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	76181	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	48630	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	388969	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	384843	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	5208229	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	5411644	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	185094	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	186231	usd
CY2024Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	27719	usd
CY2024Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	27719	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	211	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	211	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	213024	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	214161	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y2M1D
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	1830857	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	1830857	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	558157	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	506394	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1272700	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1324463	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	191130	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	267767	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	277000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	277000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	277000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	115416	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1405313	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	132613	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1272700	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	204064	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1068636	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	91777	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	102811	usd
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2017Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	250000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	99000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.13
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y9M10D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	66000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.19
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	33000	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.02
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M20D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	16200	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.03
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y9M18D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6622	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M12D
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1942	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3269	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2400000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2500000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	42248	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	42248	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	295292	usd
CY2024Q2	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	94420	usd
CY2023Q2	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	80000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-52172	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	215292	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3255887	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3255887	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-52172	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	215292	usd
CY2024Q2	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	0	usd
CY2023Q2	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	80000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-52172	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	295292	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3255887	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3255887	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1959778	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3255887	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5215665	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2696109	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	99000	shares
CY2024Q2	us-gaap	Revenues Revenues	2842176	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2096274	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	745902	usd
CY2024Q2	tikk	Tota Operatingand Nonoperatingl Expenses TotaOperatingandNonoperatinglExpenses	692424	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	53478	usd
CY2023Q2	us-gaap	Revenues Revenues	2866929	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1572380	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1294549	usd
CY2023Q2	tikk	Tota Operatingand Nonoperatingl Expenses TotaOperatingandNonoperatinglExpenses	918710	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	375839	usd
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	dei	Amendment Flag AmendmentFlag	false
CY2024Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000096885
CY2024Q2	dei	No Trading Symbol Flag NoTradingSymbolFlag	true

Files In Submission

Name	View Source	Status
0001185185-24-000796-index-headers.html	Edgar Link	pending
0001185185-24-000796-index.html	Edgar Link	pending
0001185185-24-000796.txt	Edgar Link	pending
0001185185-24-000796-xbrl.zip	Edgar Link	pending
ex_711763.htm	Edgar Link	pending
ex_711764.htm	Edgar Link	pending
ex_711765.htm	Edgar Link	pending
ex_711766.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
telinstru20240630_10q.htm	Edgar Link	pending
tikk-20240630.xsd	Edgar Link	pending
tikk-20240630_cal.xml	Edgar Link	unprocessable
tikk-20240630_def.xml	Edgar Link	unprocessable
telinstru20240630_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
tikk-20240630_lab.xml	Edgar Link	unprocessable
tikk-20240630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TIKK
TEL INSTRUMENT ELECTRONICS CORP Stock $tikk

2024 Q3 Form 10-Q Financial Statement

#000118518524000796 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TIKK TEL INSTRUMENT ELECTRONICS CORP Stock $tikk

2024 Q3 Form 10-Q Financial Statement

#000118518524000796 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TIKK
TEL INSTRUMENT ELECTRONICS CORP Stock $tikk